Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20161 AL 20175

Anesthetics and Alzheimer's disease. Editorial

Mandal PK, Fodale V.

J Alzheimers Dis. 2010;22 Suppl 3:135-6. doi: 10.3233/JAD-2010-101300.

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease

Tzimopoulou S, Cunningham VJ, Nichols TE, Searle G, Bird NP, Mistry P, Dixon IJ, Hallett WA, Whitcher B, Brown AP, Zvartau-Hind M, Lotay N, Lai RY, Castiglia M, Jeter B, Matthews JC, Chen K, Bandy D, Reiman EM, Gold M, Rabiner EA, Matthews PM.

J Alzheimers Dis. 2010;22(4):1241-56. doi: 10.3233/JAD-2010-100939.

Modern care for patients with Alzheimer disease: rationale for early intervention

Galluzzi KE, Appelt DM, Balin BJ.

J Am Osteopath Assoc. 2010 Sep;110(9 Suppl 8):S37-42.

Confronting Alzheimer's disease and other dementias

Attea P, Johns H.

J Am Geriatr Soc. 2010 Aug;58(8):1587-90. doi: 10.1111/j.1532-5415.2010.02963.x.

[Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms]

Villain N, Chételat G, Desgranges B, Eustache F.

Biol Aujourdhui. 2010;204(2):145-58. doi: 10.1051/jbio/2010010. Epub 2010 Jun 21.

Mindfulness effects on caregiver stress: should we expect more?

Khalsa DS.

J Altern Complement Med. 2010 Oct;16(10):1025-6. doi: 10.1089/acm.2010.0431.

Probable early-onset Alzheimer's disease in an apolipoprotein E2 homozygote

Cole L, Belden C, Jacobson S, Liebsack C, Myers K, Reninger C, Berk C, Sabbagh MN.

Dement Geriatr Cogn Disord. 2010;30(5):387-91. doi: 10.1159/000320589. Epub 2010 Oct 23.

Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease

Herholz K.

Expert Rev Neurother. 2010 Nov;10(11):1667-73. doi: 10.1586/ern.10.136.

Quantitative structural MRI for early detection of Alzheimer's disease

McEvoy LK, Brewer JB.

Expert Rev Neurother. 2010 Nov;10(11):1675-88. doi: 10.1586/ern.10.162.

Schizophrenia-like psychosis and dysfunction of the right-dominant temporoparietal lobe in early-onset Alzheimer's disease

Matsuoka T, Kitabayashi Y, Shibata K, Okamura A, Narumoto J, Fukui K.

J Neuropsychiatry Clin Neurosci. 2010 Fall;22(4):451-e.e8-451.e9. doi: 10.1176/jnp.2010.22.4.451.e8.

Dependence as a unifying construct in defining Alzheimer's disease severity

McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y.

Alzheimers Dement. 2010 Nov;6(6):482-93. doi: 10.1016/j.jalz.2009.09.004.

Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results

Yaffe K.

JAMA. 2010 Nov 3;304(17):1952-3. doi: 10.1001/jama.2010.1625.

[Early detection of cognitive changes in memory diseases: new cut-off scores for the Finnish version of CERAD neuropsychological battery]

Hänninen T, Pulliainen V, Sotaniemi M, Hokkanen L, Salo J, Hietanen M, Pirttilä T, Pöyhönen M, Juva K, Remes A, Erkinjuntti T.

Duodecim. 2010;126(17):2013-21.

Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease

Small G, Bullock R.

Alzheimers Dement. 2011 Mar;7(2):177-84. doi: 10.1016/j.jalz.2010.03.016. Epub 2010 Nov 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias